Stay updated on aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial
Sign up to get notified when there's something new on the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page.

Latest updates to the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page
- Check3 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous revision label. This indicates a deployment/update to the page's underlying software.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedNew help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label formatting was updated. A recruitment-closed notice ('No longer looking for participants') was added, and the revision label updated to v3.6.0 (replacing v3.5.5).SummaryDifference0.4%

- Check25 days agoChange DetectedThe study page shows a revised metadata version from v3.5.4 to v3.5.5, indicating a minor maintenance update; no changes to the study details themselves are indicated.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page now shows revision v3.5.4 instead of v3.5.3, representing an internal maintenance or update to the site's revision tracking.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision: v3.5.3 was added to the study record, replacing the previous Revision: v3.5.2. This signals a minor administrative update to the study metadata rather than any changes to the trial content or conduct.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision updated: v3.5.0 was removed and v3.5.2 was added.SummaryDifference0.1%

Stay in the know with updates to aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page.